1. Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol. 2012;4(4):68–70. https://doi.org/10.4251/wjgo.v4.i4.68.
2. Safaei A, Moghimi-Dehkordi B, Fatem SR, Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: an epidemiological study. APJCP. 2008;9(1):123–6.
3. Worthley DL, Leggett BA. Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev. 2010;31(2):31–8.
4. Nazemalhosseini Mojarad E, Kuppen PJ, Aghdaei HA, Zali MR. The CpG island methylator phenotype (CIMP) in colorectal cancer. GHFBB. 2013;6(3):120–8.
5. Peng J, Huang D, Poston G, Ma X, Wang R, Sheng W, et al. The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients. Oncotarget. 2017;8(30):49076–83. https://doi.org/10.18632/oncotarget.16176.